Corrigenda: Outcome of relapsed infant acute lymphoblastic leukemia treated on the interfant-99 protocol (Leukemia, (2016) 30, (1184-1187), 10.1038/leu.2015.246)

E. M.C. Driessen, P. De Lorenzo, M. Campbell, M. Felice, A. Ferster, I. Hann, A. Vora, L. Hovi, G. Escherich, C. K. Li, G. Mann, T. Leblanc, Franco Locatelli, A. Biondi, J. Rubnitz, M. Schrappe, L. Silverman, J. Stary, R. Suppiah, T. SzczepanskiM. Valsecchi, R. Pieters

Research output: Contribution to journalArticle

Abstract

Correction to: Leukemia (2016) 30, 1184–1187; doi:10.1038/leu.2015.246 Following the publication of this article the authors noted that the labels in Figures 1b and d have been switched. The correct labels in Figure 1b are; mixed lineage leukemia rearranged (MLL rearranged; dotted line) and unknown (thin solid line). In Figure 1d the correct labels are; bone marrow involvement (BM involv; dotted line) and isolated extramedullary (Isolated Ext; thin solid line). The authors wish to apologize for any inconvenience caused. (Figure Presented).
Original languageEnglish
Pages (from-to)2854-2854
Number of pages1
JournalLeukemia
Volume31
DOIs
Publication statusPublished - 2016

Keywords

  • N/A

Fingerprint

Dive into the research topics of 'Corrigenda: Outcome of relapsed infant acute lymphoblastic leukemia treated on the interfant-99 protocol (Leukemia, (2016) 30, (1184-1187), 10.1038/leu.2015.246)'. Together they form a unique fingerprint.

Cite this